25 Stocks Moving In Wednesday's Pre-Market Session

Gainers

• Catabasis Pharmaceuticals Inc CATB rose 60.8 percent to $4.55 in pre-market trading after the company disclosed positive results from open-label extension of Phase 2 MoveDMD trial evaluating edasalonexent.
• Capricor Therapeutics Inc CAPR rose 34.8 percent to $4.42 in pre-market trading after reporting positive six-month results in DMD at the World Muscle Society International Congress.
• CytomX Therapeutics Inc CTMX gained 32.9 percent to $25.25. Amgen, Inc. AMGN and CytomX reported a strategic collaboration in immuno-oncology.
• Medical Transcription Billing Corp MTBC shares rose 19.3 percent to $3.77 in pre-market trading after surging 109.27 percent on Tuesday.
• Viking Therapeutics Inc VKTX shares rose 18.4 percent to $2.06 in pre-market trading after the company reported 'positive' top-line results from proof-of-concept study of VK0214.
• Lilis Energy Inc LLEX rose 16.7 percent to $5.18 in pre-market trading after the company agreed to acquire over 4,000 net contiguous/overlapping acres in the core of the Delaware Basin.
• Mylan N.V. MYL rose 15.7 percent to $37.65 in the pre-market trading session after the company reported the FDA approval of first generic for Copaxone 40 mg/mL 3-times-a-week.
• Amicus Therapeutics, Inc. FOLD rose 14.3 percent to $17.00 in pre-market trading as the company announced additional positive data in Pompe disease Phase 1/2 study at the World Muscle Society.
• Celsion Corporation CLSN shares rose 12.1 percent to $6.79 in pre-market trading after jumping 301.32 percent on Tuesday.
• Intelsat SA I rose 9.7 percent to $5.89 in pre-market trading after gaining 10.95 percent on Tuesday.
• Motif Bio plc - ADR MTFB shares rose 8.3 percent to $10.95 in the pre-market trading session after the company disclosed that Iclaprim achieved primary endpoint of non-inferiority vs vancomycin in REVIVE-2 Phase 3 study.
• Retail Opportunity Investments Corp ROIC shares rose 4.8 percent to $19.90 in pre-market trading after falling 0.05 percent on Tuesday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• Momenta Pharmaceuticals, Inc. MNTA fell 24.9 percent to $13.15 in pre-market trading after dropping 2.51 percent on Tuesday.
• Teva Pharmaceutical Industries Ltd (ADR) TEVA fell 16 percent to $15.81 in pre-market trading after Mylan reported the FDA approval of first generic for Copaxone.
• Sequans Communications SA ADR SQNS shares fell 10.2 percent to $2.75 in pre-market trading after declining 0.65 percent in Tuesday.
• Endocyte, Inc. ECYT shares fell 9.9 percent to $5.30 after rising 61.98 percent on Tuesday.
• Rigel Pharmaceuticals, Inc. RIGL fell 7.5 percent to $2.99 in pre-market trading. Rigel Pharmaceuticals reported an offering of $40 million in common shares.
• Office Depot Inc ODP shares fell 6.3 percent to $4.30 in pre-market trading after the company announced plans to acquire CompuCom for $1 billion.
• Cesca Therapeutics Inc KOOL shares fell 5.4 percent to $4.55 in pre-market trading after climbing 33.61 percent on Tuesday.
• Centurylink Inc CTL fell 5.2 percent to $19.13 in pre-market trading after rising 4.51 percent on Tuesday.
• Celyad SA (ADR) CYAD shares fell 4.9 percent to $58.90 in pre-market trading after gaining 5.32 percent on Tuesday.
• NewLink Genetics Corp NLNK fell 4.8 percent to $10.40. NewLink Genetics priced 5 million share common stock offering at $10.25 per share.
• Coherus Biosciences Inc CHRS fell 4.8 percent to $12.85in pre-market trading after declining 1.82 percent on Tuesday.
• Voyager Therapeutics Inc VYGR shares fell 4.6 percent to $21.00 in pre-market trading after dropping 3.30 percent on Tuesday.
• Intercept Pharmaceuticals Inc ICPT fell 2.4 percent to $64.20 in pre-market trading. JMP Securities downgraded Intercept Pharmaceuticals from Market Outperform to Market Perform.